Drug intelligence / Profile preview

neomycin sulfate + bacitracin zinc + polymyxin b sulfate + hydrocortisone

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Ophthalmic, Topical
01

Overview

Neomycin sulfate + bacitracin zinc + polymyxin b sulfate + hydrocortisone is a fixed-dose ophthalmic ointment combining three topical antibiotics with a corticosteroid for steroid-responsive inflammatory ocular conditions in which bacterial infection is present or there is a risk of infection. Neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding the 30S ribosomal subunit; polymyxin B disrupts the outer and cytoplasmic membranes of susceptible Gram-negative bacteria through interaction with bacterial membrane phospholipids; bacitracin inhibits bacterial cell wall synthesis by interfering with dephosphorylation of the lipid carrier required for peptidoglycan precursor transport; and hydrocortisone is a glucocorticoid receptor agonist that suppresses inflammatory gene expression and leukocyte-mediated inflammation. The product has been marketed as Cortisporin and is also available generically for ophthalmic use.

Brand names
Cortisporin
Other names
neomycin sulfate + bacitracin zinc + polymyxin b sulfate + hydrocortisone ophthalmic ointmentneomycin + bacitracin + polymyxin b + hydrocortisone
02

Targets

UPP (Undecaprenyl pyrophosphate)GR (Glucocorticoid receptor)30S A-site (Bacterial ribosomal 30S A-site)

Beyond the preview

Go deeper on neomycin sulfate + bacitracin zinc + polymyxin b sulfate + hydrocortisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neomycin sulfate + bacitracin zinc + polymyxin b sulfate + hydrocortisone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call